← Back to Screener
Avantor, Inc. (AVTR)
Price$9.16
Value ScoreB
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-29.83%
Price vs S&P 500 (4W)10.24%
VGM Score46.67
Market Capitalization$6.25B
All Metrics
P/CF (Annual)10.03x
Book Value / Share (Quarterly)$8.26
P/TBV (Annual)3.30x
Revenue Growth (3Y)-4.46%
Cash Flow / Share (Quarterly)$0.65
Price vs S&P 500 (YTD)-28.23%
Gross Margin (TTM)32.13%
Net Profit Margin (TTM)-8.42%
EPS (TTM)$-0.81
10-Day Avg Trading Volume10.26M
EPS Excl Extra (TTM)$-0.81
Revenue Growth (5Y)0.49%
EPS (Annual)$-0.78
Dividend / Share (Annual)$0.00
ROI (Annual)-5.57%
Gross Margin (Annual)32.65%
Net Profit Margin (5Y Avg)4.78%
Cash / Share (Quarterly)$0.41
Revenue Growth QoQ (YoY)0.00%
ROA (Last FY)-4.50%
Revenue Growth TTM (YoY)-1.99%
EBITD / Share (TTM)$0.17
ROE (5Y Avg)7.26%
Operating Margin (TTM)-4.57%
Cash Flow / Share (Annual)$0.73
P/B Ratio1.12x
P/B Ratio (Quarterly)0.95x
Net Income / Employee (Annual)$-39,300
EV / Revenue (TTM)1.49x
Net Interest Coverage (TTM)-1.49x
ROA (TTM)-4.60%
EPS Growth QoQ (YoY)-32.28%
EV / EBITDA (TTM)84.26x
EPS Incl Extra (Annual)$-0.78
Current Ratio (Annual)1.78x
Quick Ratio (Quarterly)1.17x
3-Month Avg Trading Volume10.70M
52-Week Price Return-29.27%
EV / Free Cash Flow (Annual)19.78x
Revenue / Employee (TTM)$485,300
Tangible BV / Share (Quarterly)$3.68
P/S Ratio (Annual)0.95x
Asset Turnover (Annual)0.56x
52-Week High$15.93
Operating Margin (5Y Avg)9.95%
EPS Excl Extra (Annual)$-0.78
CapEx CAGR (5Y)15.90%
26-Week Price Return-21.91%
Quick Ratio (Annual)1.18x
13-Week Price Return7.51%
Total Debt / Equity (Annual)0.71x
Current Ratio (Quarterly)1.76x
Enterprise Value$9.79B
Revenue / Share Growth (5Y)-2.56%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)12.09%
Revenue / Employee (Annual)$485,300
Inventory Turnover (Annual)5.70x
Pretax Margin (Annual)-6.74%
Cash / Share (Annual)$0.54
3-Month Return Std Dev41.60%
Gross Margin (5Y Avg)33.74%
Net Income / Employee (TTM)$-40,800
EBITDA Interim CAGR (5Y)-10.25%
ROE (Last FY)-9.53%
Net Interest Coverage (Annual)-1.69x
EPS Basic Excl Extra (Annual)$-0.78
P/FCF (TTM)14.25x
Receivables Turnover (TTM)5.95x
EV / Free Cash Flow (TTM)22.31x
Total Debt / Equity (Quarterly)0.68x
EPS Incl Extra (TTM)$-0.81
Receivables Turnover (Annual)6.21x
ROI (TTM)-5.67%
P/S Ratio (TTM)0.95x
Pretax Margin (5Y Avg)6.65%
Revenue / Share (Annual)$9.63
Tangible BV / Share (Annual)$3.48
Forward P/E11.62x
Free OCF CAGR (5Y)-10.63%
Price vs S&P 500 (52W)-53.63%
Year-to-Date Return-20.07%
5-Day Price Return-0.33%
EPS Normalized (Annual)$-0.78
ROA (5Y Avg)2.61%
Net Profit Margin (Annual)-8.09%
Month-to-Date Return0.44%
Cash Flow / Share (TTM)$1.13
EBITD / Share (Annual)$-0.36
Operating Margin (Annual)-3.83%
LT Debt / Equity (Annual)0.70x
P/CF (TTM)10.91x
ROI (5Y Avg)3.16%
LT Debt / Equity (Quarterly)0.68x
EPS Basic Excl Extra (TTM)$-0.81
P/TBV (Quarterly)2.13x
P/B Ratio (Annual)1.40x
Inventory Turnover (TTM)5.70x
Pretax Margin (TTM)-7.20%
Book Value / Share (Annual)$8.16
Price vs S&P 500 (13W)-0.74%
Beta0.95x
P/FCF (Annual)12.63x
Revenue / Share (TTM)$9.68
ROE (TTM)-9.59%
52-Week Low$7.26
vGradeB
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.17est. 0.16
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.31
2.80
2.79
3.32
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AVTRAvantor, Inc. | B | D | C | $9.16 |
| AAgilent Technologies Inc. | C | C | B | $135.44 |
| WATWaters Corp | D | C | C | $365.36 |
| ILMNIllumina Inc | D | D | B | $162.32 |
| MTDMettler-Toledo International | D | C | C | $1154.33 |
| RVTYRevvity, Inc. | C | D | C | $98.37 |
| BRKRBruker Corporation | D | D | B | $56.39 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $294.32 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $31.04 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | — | A | $20.54 |
About
Avantor supplies essential laboratory products, equipment, and services to life sciences, healthcare, and advanced materials industries globally. The company operates two segments—Laboratory Solutions and Bioscience Production—offering high-purity chemicals, reagents, lab consumables, chromatography products, and specialized procurement services. Its portfolio serves biopharma, healthcare, government, and advanced technology customers across the Americas, Europe, and AMEA.